Open original FDA record ↗Recall record
- FDA identifier
- Z-0978-2025
- Company in FDA record
- Integra LifeSciences Corp.
- FDA classification date
- Jan 17, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for certain SKUs and lot numbers were distributed with the incorrect product description on the internal and external labels.
Source facts
- Action
- Integra LifeSciences notified consignees on about 12/16/2024 via letter. Consignees were instructed to review and understand the information provided in the letter, complete and return the provided Customer Acknowledgement Form, remove any affected units from service and quarantine them, arrange for return of affected units, and forward the notification to anyone who utilizes the affected units. Distributors were instructed to follow the same directions but also requested to notify any customers if product was further distributed, and return affected units.
- Initiated
- 2024-12-16
- Root cause
- Labeling Change Control
- Distribution
- US Nationwide distribution in the states of FL, NC, MA, MN, OH, DC, VA, CA, WI, NE, TX, NY, MI, OR, NJ, SC, AZ, UT, RI, IN, GA, CO and the countries of Canada, Australia, New Zealand, Cyprus, Sweden, Finland, Slovenia and Great Britain.
- Recall number
- Z-0978-2025
- Recall status
- Open, Classified
- CDRH record ID
- 211622
- FDA classified
- 2025-01-17
- Recall event number
- 95951